We are live on ! Find out more
DNLI icon

Denali Therapeutics
DNLI

90 hedge funds and large institutions have $1.41B invested in Denali Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

15% more funds holding

Funds holding: 78 → 90 (+12)

1.09% more ownership

Funds ownership: 70.64% → 71.72% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $1.46B → $1.41B (-$49.1M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
90
Holders Change
+12
Holders Change %
+15.38%
% of All Funds
2.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
25
Increased
33
Reduced
21
Closed
13
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$9K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$31.3M
2
BlackRock
BlackRock
New York
+$23M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$13.4M
4
State Street
State Street
Massachusetts
+$11.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$5.68M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$38.8M
2
Fidelity International
Fidelity International
Bermuda
-$25.2M
3
CM
Crestline Management
Texas
-$20.2M
4
FCMI
Foresite Capital Management II
California
-$5.43M
5
NTC
NF Trinity Capital
Hong Kong
-$2.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
GHCM
76
Glen Harbor Capital Management
California
$16K +$13.7K +756 New
Daiwa Securities Group
77
Daiwa Securities Group
Japan
$16K +$13.9K +765 New
Bank of Montreal
78
Bank of Montreal
Ontario, Canada
$13K +$6.04K +333 +106%
MCIM
79
Meadow Creek Investment Management
Georgia
$12K +$10.8K +594 New
PNC Financial Services Group
80
PNC Financial Services Group
Pennsylvania
$10K -$653 -36 -7%
FCM
81
Flinton Capital Management
Pennsylvania
$9K +$7.84K +432 New
MAM
82
Meeder Asset Management
Ohio
$7K -$1.43K -79 -20%
CHP
83
Cable Hill Partners
Oregon
$6K +$5.44K +300 New
LTFS
84
Ladenburg Thalmann Financial Services
Florida
$4K – – –
RE
85
RBC Europe
United Kingdom
$2.07K – – –
CG
86
Cutler Group
California
$2K +$1.81K +100 New
Group One Trading
87
Group One Trading
Illinois
$2K +$1.81K +100 New
TRCT
88
Tower Research Capital (TRC)
New York
$2K +$1.94K +107 New
HR
89
Howe & Rusling
New York
$1K +$1.2K +66 New
AAMU
90
Amundi Asset Management US
Massachusetts
$194 +$171K +9,400 New
FCMI
91
Foresite Capital Management II
California
– -$5.43M -250,000 Closed
NTC
92
NF Trinity Capital
Hong Kong
– -$2.44M -112,273 Closed
BP
93
Ballentine Partners
Massachusetts
– -$544K -25,000 Closed
Barclays
94
Barclays
United Kingdom
– -$371K -17,071 Closed
DADC
95
D.A. Davidson & Co
Montana
– -$344K -15,833 Closed
BCM
96
BlueCrest Capital Management
Jersey
– -$324K -14,900 Closed
Man Group
97
Man Group
United Kingdom
– -$228K -10,488 Closed
Jane Street
98
Jane Street
New York
– -$218K -10,020 Closed
Mitsubishi UFJ Asset Management
99
Mitsubishi UFJ Asset Management
Japan
– -$40K -1,830 Closed
Simplex Trading
100
Simplex Trading
Illinois
– -$24K -1,114 Closed
1 2 3
4
5

DNLI Hedge Fund Activity: Q4 2018 in Review

90 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Denali Therapeutics (DNLI) for Q4 2018, worth a combined $1.41B — down 3.4% from $1.46B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new DNLI positions and 13 closed out — a net gain of 12 holders — while 33 added to existing stakes and 21 trimmed.

The largest buyer was Vanguard Group, adding an estimated $31.3M. The largest seller was Fidelity Investments, cutting an estimated $38.8M.

  • 90 institutional investors held Denali Therapeutics (DNLI) as of Q4 2018, up from 78 in Q3 2018.
  • Funds reported $1.41B of Denali Therapeutics stock for Q4 2018, down 3.4% quarter-over-quarter.
  • 25 funds opened new Denali Therapeutics positions in Q4 2018 and 13 closed out, a net change of +12 holders.
  • The largest Denali Therapeutics buyer in Q4 2018 was Vanguard Group, an estimated $31.3M added.
  • The largest Denali Therapeutics seller in Q4 2018 was Fidelity Investments, an estimated $38.8M sold.

Based on aggregated 13F filings for Q4 2018.